The feasibility study is focussing on Modified Vaccinia Ankara (MVA) virus as a first example for IDT's broad range of vector technologies
To Develop Large-scale Manufacturing Process For V | 02/03/2022 | By Darshana | 505
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy